P

Inventor

SCIAVOLINO FRANK C

US36 patents
⚠️ This page may combine multiple inventors who share the name “SCIAVOLINO FRANK C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PFIZER

20 patents
US4565653AJan 21, 1986

Acyltripeptide immunostimulants

PFIZER101 citations94
US4382086AMay 3, 1983

9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin A

PFIZER18 citations82
US4150220AApr 17, 1979

Semi-synthetic 4"-erythromycin A derivatives

PFIZER16 citations74
US4090017AMay 16, 1978

4-Deoxy-4-substituted amino derivatives of oleandomycin

PFIZER16 citations74
US4069379AJan 17, 1978

Semi-synthetic oleandomycins

PFIZER9 citations74
US4036853AJul 19, 1977

Semi-synthetic oleandomycin derivatives-C8 modifications

PFIZER7 citations74
US4129578ADec 12, 1978

Polycyclic ether antibiotic

PFIZER12 citations73
US4382085AMay 3, 1983

4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents

PFIZER15 citations71
US4283527AAug 11, 1981

Erythromycylamine 11,12-carbonate and derivatives thereof

PFIZER5 citations63
US4180654ADec 25, 1979

4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate

PFIZER4 citations63
US4125705ANov 14, 1978

Semi-synthetic 4-amino-oleandomycin derivatives

PFIZER3 citations63
US4110531AAug 29, 1978

Semi-synthetic oleandomycin derivatives - C8 modifications

PFIZER1 citations63
US4110530AAug 29, 1978

Semi-synthetic oleandomycin derivatives - C8 modifications

PFIZER1 citations63
US4013789AMar 22, 1977

Mixture of antibiotics produced by new species of micromonospora

PFIZER4 citations62
US4189590AFeb 19, 1980

Semi-synthetic oleandomycin derivatives--C8 modifications

PFIZER0 citations52
US4188479AFeb 12, 1980

Semi-synthetic oleandomycin derivatives-C8 modifications

PFIZER0 citations52
US4182857AJan 8, 1980

Semi-synthetic oleandomycin derivatives - C8 modifications

PFIZER0 citations52
US4182858AJan 8, 1980

Semi-synthetic oleandomycin derivatives - C8 modifications

PFIZER0 citations52
US4178436ADec 11, 1979

Semi-synthetic oleandomycin derivatives-C8 modifications

PFIZER1 citations52
US4062944ADec 13, 1977

Mixture of antibiotics produced by new species of micromonospora

PFIZER0 citations52

THETIS PHARMACEUTICALS LLC

16 patents
US8933124B2Jan 13, 2015

Tri-salt form of metformin

THETIS PHARMACEUTICALS LLC8 citations84
US8765811B2Jul 1, 2014

Tri-salt form of metformin

THETIS PHARMACEUTICALS LLC11 citations84
US9242008B2Jan 26, 2016

Mineral amino-acid complexes of fatty acids

THETIS PHARMACEUTICALS LLC8 citations82
US9505709B2Nov 29, 2016

Compositions and methods relating to ionic salts of peptides

THETIS PHARMACEUTICALS LLC6 citations72
US10420843B2Sep 24, 2019

Compositions and methods relating to salts of specialized pro-resolving mediators

THETIS PHARMACEUTICALS LLC3 citations71
US10130719B2Nov 20, 2018

Compositions and methods relating to salts of specialized pro-resolving mediators

THETIS PHARMACEUTICALS LLC3 citations71
US9999626B2Jun 19, 2018

Mineral amino-acid complexes of active agents

THETIS PHARMACEUTICALS LLC4 citations71
US9216951B2Dec 22, 2015

Lipid-lowering antidiabetic agent

THETIS PHARMACEUTICALS LLC1 citations63
US9012507B2Apr 21, 2015

Lipid-lowering antidiabetic agent

THETIS PHARMACEUTICALS LLC1 citations63
US8901107B2Dec 2, 2014

Lipid-lowering antidiabetic agent

THETIS PHARMACEUTICALS LLC2 citations63
US11925688B2Mar 12, 2024

Compositions and methods relating to salts of specialized pro-resolving mediators

THETIS PHARMACEUTICALS LLC0 citations60
US11191840B2Dec 7, 2021

Compositions and methods relating to salts of specialized pro-resolving mediators

THETIS PHARMACEUTICALS LLC0 citations60
US11135298B2Oct 5, 2021

Compositions and methods relating to salts of specialized pro-resolving mediators

THETIS PHARMACEUTICALS LLC0 citations60
US12564644B2Mar 3, 2026

Cyclodextrin complexes of specialized proresolving mediators

THETIS PHARMACEUTICALS LLC0 citations55
US9382187B2Jul 5, 2016

Tri-salt form of metformin

THETIS PHARMACEUTICALS LLC1 citations52
US11986512B2May 21, 2024

Compositions and methods for cancer therapy

THETIS PHARMACEUTICALS LLC0 citations44